Status:
COMPLETED
Pulsed Radiofrquency Targeting Mid Cervical Medial Branches Versus GON for Cervicogenic Headache
Lead Sponsor:
Assiut University
Conditions:
Cervicogenic Headache
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
To detect the Clinical efficacy of pulsed radiofrequency treatment targeting the mid cervical medial branches versus greater occipital nerve for cervicogenic headache
Detailed Description
Cervicogenic headache (CHA) is one of the secondary headache disorders. The prevalence of CHA was estimated to be \~4.1%, and most of the patients affected by CHA report un-resolved, recurrent throbbi...
Eligibility Criteria
Inclusion
- medically stable outpatients with confirmed diagnosis of cervicogenic headache according to International Headache society
- Are reliable and willing to make themselves available for the duration of the study and are willing to follow up.
- Men or women older than 18years of age .
- clear written informed consent from each participant in the trial.
Exclusion
- 1)pregnants, breastfeeding, or willing to be pregnant during the study.
- 2)presence of clinically significant medical or psychiatric condition that may increase the risk associated with the study 3)participation in any other type of medical research that may interfere with the interpretation of the study.
- 4)patients with haemocoagulation disorders, local infection or those who refused to consent
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05289414
Start Date
September 1 2022
End Date
December 31 2024
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tarek
Asyut, Egypt